Republication or reproduction of this report or its storage and/or dissemination by electronic means is
accumulation (in biology)
See bioaccumulation.
activation (in biology)
See bioactivation.
active metabolite
Metabolite with biological and/or toxicological activity. See also metabolite.
Of short duration, in relation to exposure or effect.
In experimental toxicology, acute refers to studies where dosing is either single or limited to one day, although the total study duration may extend to two weeks.
2.
In clinical medicine, sudden and severe, having a rapid onset.
After [20] Antonym: chronic acute effect Effect of finite duration occurring rapidly (usually in the first 24 h or up to 14 d) following a single dose or short exposure to a substance or radiation. After [20] acute exposure Exposure of short duration. See also acute, exposure. Antonym: chronic exposure acute toxicity 1.
Adverse effects of finite duration occurring within a short time (up to 14 d) after administration of a single dose (or exposure to a given concentration) of a test substance or after multiple doses (exposures), usually within 24 h of a starting point (which may be exposure to the toxicant, or loss of reserve capacity, or developmental change, etc.).
Ability of a substance to cause adverse effects within a short time of dosing or exposure.
adsorption factor
Ratio of the amount of substance adsorbed at the interface of a condensed and a liquid or gaseous phase to the total amount of the substance available for adsorption.
advection (in environmental chemistry) Process of transport of a substance in air or water solely by mass motion.
adverse effect
Change in biochemistry, morphology, physiology, growth, development, or lifespan of an organism which results in impairment of functional capacity or impairment of capacity to compensate for additional stress or increase in susceptibility to other environmental influences.
After [59] aerodynamic diameter (of a particle) Diameter of a spherical particle with relative density equal to unity, which has the same settling velocity in air as the particle in question.
After [28] aerosol Mixtures of small particles (solid, liquid, or a mixed variety) and the carrier gas (usually air).
Note 1:
Owing to their size, these particles (usually less than 100 µm and greater than 0.01 µm in diameter) have a comparatively small settling velocity and hence exhibit some degree of stability in the earth's gravitational field.
Note 2: An aerosol may be characterized by its chemical composition, its radioactivity, the particle size distribution, the electrical charge, and the optical properties.
[ 38] aliquot (in analytical chemistry) Known amount of a homogeneous material, assumed to be taken with negligible sampling error.
The term is usually applied to fluids.
Note 2:
The term "aliquot" is usually used when the fractional part is an exact divisor of the whole; the term "aliquant" has been used when the fractional part is not an exact divisor of the whole (e.g., a 15-ml portion is an aliquant of 100 ml).
Note 3:
When an aliquot is taken of a laboratory sample or test sample or the sample is otherwise subdivided, the samples have been called split samples. [38] allometric Pertaining to a systematic relationship between growth rates of different parts of an organism and its overall growth rate.
allometric growth
Regular and systematic pattern of growth such that the mass or size of any organ or part of a body can be expressed in relation to the total mass or size of the entire organism according to the allometric equation:
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where Y = mass of the organ, x = mass of the organism, α = growth coefficient of the organ, and b = a constant.
[45]
allometric scaling 1. Adjustment of data to allow for change in proportion between an organ or organs and other body parts during the growth of an organism.
2.
Adjustment of data to allow for differences and make comparisons between species having dissimilar characteristics, for example, in size and shape.
After [19] allometry (in biology) Measurement of the rate of growth of a part or parts of an organism relative to the growth of the whole organism.
antagonism Combined effect of two or more factors, which is smaller than the solitary effect of any one of those factors. In bioassays, the term may be used when a specified effect is produced by exposure to either of two factors, but not by exposure to both together. [20, 38] 
1.
Caused by or influenced by human activities.
2.
Describing a conversion factor used to calculate a dose or concentration affecting a human that has been derived from data obtained with another species (e.g., the rat).
Bateman function
Equation expressing the build-up and decay in concentration of a substance (usually in plasma) based on first-order uptake and elimination in a one-compartment model, having the form
exp(-k e t) -exp(-k a t)]
where C is the concentration and D the dose of the substance, f the fraction absorbed, and V the volume of distribution. k a and k e are the first-order rate constants of uptake and elimination, respectively, and t is time.
benchmark concentration
Statistical lower confidence limit on the concentration that produces a defined response (called the benchmark response or BMR, usually 5 or 10 %) for an adverse effect compared to background, defined as 0 %. After [29] benchmark dose Statistical lower confidence limit on the dose that produces a defined response (called the benchmark response or BMR, usually 5 or 10 %) of an adverse effect compared to background, defined as 0 %. After [29] benchmark guidance value Biological monitoring guidance value set at the 90 th percentile of available biological monitoring results collected from a representative sample of workplaces with good occupational hygiene practices. [71] benchmark response Response expressed as an excess of background, at which a benchmark dose or benchmark concentration is set. After [29] bioaccumulation Progressive increase in the amount of a substance in an organism or part of an organism which occurs because the rate of intake exceeds the organism's ability to remove the substance from the body. See also bioconcentration, biomagnification.
bioactivation Metabolic conversion of a xenobiotic to a more toxic derivative. [20] bioassay Procedure for estimating the concentration or biological activity of a substance by measuring its effect on a living system compared to a standard system. Modified from [38, 42] bioavailability (general) Extent of absorption of a substance by a living organism compared to a standard system. Synonyms: biological availability, physiological availability M. NORDBERG et al.
bioavailability (in pharmacokinetics)
Ratio of the systemic exposure from extravascular (ev) exposure to that following intravenous (iv) exposure as described by the equation:
where F is the bioavailability, A and B are the areas under the (plasma) concentration-time curve following extravascular and intravenous administration respectively, and D ev and D iv are the administered extravascular and intravenous doses. After [20] bioconcentration Process leading to a higher concentration of a substance in an organism than in environmental media to which it is exposed. After [51] See also bioaccumulation.
bioconcentration factor, BCF Measure of the tendency for a substance in water to accumulate in organisms, especially fish. The equilibrium concentration of a substance in fish can be estimated by multiplying its concentration in the surrounding water by its bioconcentration factor in fish. This parameter is an important determinant for human intake of aquatic food by the ingestion route. After [53] bioconjugate See conjugate.
bioconversion See synonym biotransformation.
bioinactivation
Metabolic conversion of a xenobiotic to a less toxic derivative.
biokinetics (in toxicology)
Science of the movements involved in the distribution of substances. After [19] biological assessment of exposure See biological monitoring.
biological exposure indices, BEI Guidance value recommended by ACGIH for assessing biological monitoring results.
biological half life
For a substance, the time required for the amount of that substance in a biological system to be reduced to one half of its value by biological processes, when the rate of removal is approximately exponential. [38] biological half time, [20]
biomarker of effect Biomarker that, depending on its magnitude, can be recognized as associated with an established or possible health impairment or disease. [68] biomarker of exposure Biomarker that relates exposure to a xenobiotic to the levels of the substance or its metabolite, or of the product of an interaction between the substance and some target molecule or cell that can be measured in a compartment within an organism. [68] biomarker of susceptibility Biomarker of an inherent or acquired ability of an organism to respond to exposure to a specific substance. [68] biomonitoring See synonym biological monitoring.
biotransformation Chemical conversion of a substance that is mediated by living organisms or enzyme preparations derived therefrom. [38, 42] blood-brain barrier Barrier formed by the blood vessels and supporting tissues of the brain that prevents some substances from entering the brain from the blood.
blood-testis barrier
Membranous barrier separating the blood from the spermatozoa of the seminiferous tubules and consisting of specific junctional complexes between Sertoli cells. After [19] M. NORDBERG et al.
blood plasma
See plasma (in biology).
body burden
Total amount of a substance present in an organism at a given time.
After [20] carcinogen n., -ic adj. Agent (chemical, physical, or biological) which is capable of increasing the incidence of malignant neoplasms. [26] carrier Substance in appreciable amount which, when associated with a trace of a specified substance, will carry the trace with it through a chemical or physical process. [38] carrier-linked prodrug, carrier prodrug Compound that contains a temporary linkage between a given active substance and a transient carrier group, the latter producing improved physicochemical or pharmacokinetic properties and easily removable in vivo. After [57] carrier protein 1.
Protein to which a specific ligand or hapten is conjugated.
2.
Unlabeled protein introduced into an assay at relatively high concentrations which distributes in a fractionation process in the same manner as labeled protein analyte, present in very low concentrations.
3.
Protein added to prevent nonspecific interaction of reagents with surfaces, sample components, and each other [10] . 4 .
Protein found in cell membranes, which facilitates transport of a ligand across the membrane.
carrier substance Substance which binds to another substance and transfers it from one site to another.
ceiling value, CV Airborne concentration of a potentially toxic substance which should never be exceeded in a worker's breathing zone.
After [20] cell line Defined unique population of cells obtained by culture from a primary source through numerous generations. After [20] See also transformed cell line.
chemical conversion
Change from one chemical species to another. After [20] chemical species (of an element) Specific form of an element defined as to isotopic composition, electronic or oxidation state, and/or complex or molecular structure. [52] chronic Long-term (in relation to exposure or effect).
1.
In experimental toxicology, chronic refers to mammalian studies lasting considerably more than 90 days or to studies occupying a large part of the lifetime of an organism.
2.
In clinical medicine, long established or long lasting. Antonym: acute chronic effect Consequence that develops slowly and/or has a long lasting course: may be applied to an effect that develops rapidly and is long lasting. After [61] Antonym: acute effect Synonym: long-term effect chronic exposure Continued exposures occurring over an extended period of time, or a significant fraction of the test species' or of the group of individuals', or of the population's lifetime. [20] Antonym: acute exposure Synonym: long-term exposure chronic toxicity 1.
Adverse effects following chronic exposure.
Effects which persist over a long period of time whether or not they occur immediately upon exposure or are delayed. [20] Antonym: acute toxicity chronotoxicology Study of the influence of biological rhythms on the toxicity of substances. [20] clearance (general), (c o /c i )(∆V/∆t) Product of the concentration c o of a component in an output system and the volume flow rate of the output system divided by the concentration c i of this component in the input system.
Note:
The term "mean volume rate" is recommended for this quantity. [38] clearance (in toxicology) 1.
Volume of blood or plasma or mass of an organ effectively cleared of a substance by elimination (metabolism and excretion) divided by time of elimination.
Note: Total clearance is the sum of the clearances of each eliminating organ or tissue for a given substance.
M. NORDBERG et al.
2.
(in pulmonary toxicology) Volume or mass of lung cleared divided by time of elimination; used qualitatively to describe removal of any inhaled substance which deposits on the lining surface of the lung. 3.
(in renal toxicology) Quantification of the removal of a substance by the kidneys by the processes of filtration and secretion; clearance is calculated by relating the rate of renal excretion to the plasma concentration. [20] comparative risk See relative excess risk.
compartment
Conceptualized part of the body (organs, tissues, cells, or fluids) considered as an independent system for purposes of modeling and assessment of distribution and clearance of a substance. After [61] compartmental analysis Mathematical process leading to a model of transport of a substance in terms of compartments and rate constants, usually taking the form
where each exponential term represents one compartment. C is the substance concentration; A, B, … are proportionality constants; α, β, … are rate constants; and t is time.
Any one of a group of three quantities characterizing the composition of a mixture and defined as one of mass, amount of substance (chemical amount), or number divided by volume, giving, respectively, mass, amount (of substance), or number concentration.
2.
Short form for amount (of substance) concentration (substance concentration in clinical chemistry). Modified from [38] concentration-effect curve Graph of the relation between exposure concentration and the magnitude of the resultant biological change. [20] Synonym: exposure-effect curve concentration-effect relationship Association between exposure concentration and the resultant magnitude of the continuously graded change produced, either in an individual or in a population. After [20] concentration-response curve Graph of the relation between exposure concentration and the proportion of individuals in a population responding with a defined effect. After [20] concentration-response relationship Association between exposure concentration and the incidence of a defined effect in an exposed population. After [20] congener One of two or more substances related to each other by origin, structure, or function. After [20] conjugate 1.
Molecular species produced in living organisms by covalently linking two chemical moities from different sources.
Example: A conjugate of a xenobiotic with some group such as glutathione, sulfate or glucuronic acid, making it soluble in water or compartmentalized within the cell.
[38] See also phase II reaction.
Material produced by attaching two or more substances together, e.g., a conjugate of an antibody with a fluorochrome or enzyme. After [20] convection (as applied to air and water motion) Vertical motion of the air or of water, induced by the expansion of the air or water, heated by the earth's surface, or by human activity, and its resulting buoyancy. After [38] conversion See chemical conversion, biotransformation.
count mean diameter
Mean of the diameters of all particles in a population. [65] See also mass mean diameter.
count median diameter
Calculated diameter in a population of particles in a gas or liquid phase above which there are as many particles with larger diameters as there are particles below it with smaller diameters. [65] See also mass median diameter.
critical concentration (for a cell or an organ) Concentration of a substance at and above which adverse functional changes, reversible or irreversible, occur in a cell or an organ. [20] critical dose Dose of a substance at and above which adverse functional changes, reversible or irreversible, occur in a cell or an organ. critical effect For deterministic effects, the first adverse effect which appears when the threshold (critical) concentration or dose is reached in the critical organ: adverse effects with no defined threshold concentration are regarded as critical. After [65] critical end-point Toxic effect used by the USEPA as the basis for a reference dose. [5] critical group Part of a target population most in need of protection because it is most susceptible to a given toxicant. [61] critical organ (in toxicology) Organ that attains the critical concentration of a substance and exhibits the critical effect under specified circumstances of exposure and for a given population. After [20] critical organ concentration (of a substance) Mean concentration of a substance in the critical organ at the time the substance reaches its critical concentration in the most sensitive type of cell in the organ. [20] critical period (of development) Stage of development of an organism that is of particular importance in the life cycle if the normal full development of some anatomical, physiological, metabolic, or psychological structure or function is to be attained. After [20] critical study Investigation yielding the no observed adverse effect level that is used by the USEPA as the basis of the reference dose. [5] Synonym: pivotal study cumulative effect Overall change which occurs after repeated doses of a substance or radiation. After [20] cumulative incidence Number or proportion of individuals in a group who experience the onset of a health-related event during a specified time interval.
Note: This interval is generally the same for all members of the group, but, as in lifetime incidence, it may vary from person to person without reference to age.
After [35] Synonym: incidence proportion cumulative incidence rate Proportion of the cumulative incidence to the total population. After [35] cumulative median lethal dose Estimate of the total administered amount of a substance which is associated with the death of half a population of animals when the substance is administered repeatedly in doses which are generally fractions of the median lethal dose. After [20] cytochromes Conjugated proteins containing haem as the prosthetic group and associated with electron transport and with redox processes. [38] cytochrome P450 Member of a superfamily of heme-containing monooxygenases involved in xenobiotic metabolism, cholesterol biosynthesis, and steroidogenesis, in eukaryotic organisms found mainly in the endoplasmic reticulum and inner mitochondrial membrane of cells. 'P450' refers to a feature in the carbon monoxide absorption difference spectrum at 450 nm caused by the presence of a thiolate in the axial position of the heme opposite to the carbon monoxide ligand. deterministic effect, deterministic process Phenomenon committed to a particular outcome determined by fundamental physical principles. See also stochastic effect.
Process, or processes, of chemical modification which make a toxic molecule less toxic.
2.
Treatment of patients suffering from poisoning in such a way as to promote physiological processes which reduce the probability or severity of harmful effects. [20, 38] diffusion Spontaneous differential movement of components in a system. Note: In molecular terms, the driving force for diffusion is random thermal motion. In thermodynamic terms, the driving force is a gradient of chemical potential. [38] dispersion (in environmental chemistry) Dilution of a pollutant by spreading in the atmosphere or water due to diffusion or turbulent action. After [38] M. NORDBERG et al.
Natural tendency shown by an individual or group of individuals, including any tendency to acquisition of specific diseases, often due to hereditary factors. [20] 2.
Total of the processes of absorption of a chemical into the circulatory systems, distribution throughout the body, biotransformation, and excretion.
Apportionment of a solute between two phases. The terms "partition" or "extraction" may also be used in this sense where appropriate. [38] 2.
Dispersal of a substance and its derivatives throughout the natural environment or throughout an organism.
3.
Final location(s) of a substance within an organism after dispersal. After [20] distribution constant See partition ratio, distribution volume Theoretical volume of a body compartment throughout which a substance is calculated to be distributed.
dominant half life
Half life of a fraction of a substance in a specific organ or compartment if it defines approximately the overall clearance rate for that substance at a specific time point.
dosage Dose divided by product of mass of organism and duration of dose.
Note: Often expressed mg (kg body weight) -1 day -1 and may be used as a synonym for dose.
[20]
dose (of a substance) Total quantity of a substance administered to, taken up, or absorbed by an organism, organ, or tissue. After [20] dose (of radiation) Energy or amount of photons absorbed by an irradiated object during a specified exposure time divided by area or volume. After [38] dose-effect Relation between dose and the magnitude of a measured biological change.
dose-effect curve
Graph of the relation between dose and the magnitude of the biological change produced measured in appropriate units. [20] dose-effect relationship Association between dose and the resulting magnitude of a continuously graded change, either in an individual or in a population. After [20] dose-response curve Graph of the relation between dose and the proportion of individuals in a population responding with a defined biological effect. [20] dose-response relationship Association between dose and the incidence of a defined biological effect in an exposed population usually expressed as percentage. After [20] elimination (in toxicology) Disappearance of a substance from an organism or a part thereof, by processes of metabolism, secretion, or excretion.
After [61] See also clearance.
elimination rate
Differential with respect to time of the concentration or amount of a substance in the body, or a part thereof, resulting from elimination.
endocytosis
Uptake of material into a cell by invagination of the plasma membrane and its internalization in a membrane-bounded vesicle. [3] See also phagocytosis, pinocytosis.
endogenous Produced within or caused by factors within an organism.
endothelium Layer of flattened epithelial cells lining the heart, blood vessels, and lymphatic vessels.
enterohepatic circulation
Cyclical process involving intestinal re-absorption of a substance that has been excreted through the bile, followed by transfer back to the liver, making it available for biliary excretion again. After [20] environmental monitoring Continuous or repeated measurement of agents in the environment to evaluate environmental exposure and possible damage by comparison with appropriate reference values based on knowledge of the probable relationship between ambient exposure and resultant adverse effects.
enzyme induction
Process whereby an enzyme is synthesized in response to the presence of a specific substance or to other agents such as heat or a metal.
Modified from [38] epithelium Sheet of one or more layers of cells covering the internal and external surfaces of the body and hollow organs.
equilibrium State of a system in which the defining variables (temperature, pressure, chemical potential) have constant values.
excretion Discharge or elimination of an absorbed or endogenous substance, or of a waste product, and/or its metabolites, through some tissue of the body and its appearance in urine, feces, or other products normally leaving the body.
Note: Excretion does not include the passing of a substance through the intestines without absorption.
After [65] See also clearance, elimination.
excretion rate Amount of substance and/or its metabolites that is excreted divided by time of excretion. [20] exogenous substance See preferred synonym: xenobiotic.
exponential decay Variation of a quantity according to the law
where A and A 0 are the values of the quantity being considered at time t and zero respectively, and λ is an appropriate positive constant.
[38]
Concentration, amount or intensity of a particular physical or chemical agent or environmental agent that reaches the target population, organism, organ, tissue, or cell, usually expressed in numerical terms of concentration, duration, and frequency (for chemical agents and microorganisms) or intensity (for physical agents).
[20] 2.
Process by which a substance becomes available for absorption by the target population, organism, organ, tissue, or cell, by any route. [20] 3.
For X-or γ-radiation in air, the sum of the electrical charges of all the ions of one sign produced when all electrons liberated by photons in a suitably small element of volume of air completely stopped, divided by the mass of the air in the volume element. [38] exposure assessment Process of measuring or estimating concentration (or intensity), duration, and frequency of exposures to an agent that is present in the environment or, if estimating hypothetical exposures, that might arise from the release of a substance, or radionuclide, into the environment. [20] exposure-effect curve See concentration-effect curve. extracellular space Volume within a tissue, outside cells, and excluding vascular and lymphatic space.
extracellular volume
Volume of fluid outside the cells but within the outer surface of an organism.
extraction ratio Amount of substance extracted from a source divided by the total contained within the source.
first-order process 1.
Chemical reaction where the rate is directly proportional to the concentration of reactant. [10] 2.
Any reaction changing at a constant fractional rate. Synonym: first-order reaction first-pass effect Biotransformation and, in some cases, elimination of a substance in the liver after absorption from the intestine and before it reaches the systemic circulation. After [20] first-pass metabolism See first-pass effect.
foreign substance See preferred synonym: xenobiotic. fractionation Process of classification of an analyte or a group of analytes from a sample according to physical (e.g., size, solubility) or chemical (e.g., bonding, reactivity) properties. [52] gavage Administration of materials directly into the stomach by oesophageal intubation. [20] M. NORDBERG et al.
genetic polymorphism
Existence of inter-individual differences in DNA sequences coding for one specific gene giving rise to different physical and/or metabolic traits.
Science of using DNA-and RNA-based technologies to demonstrate alterations in gene expression. 2.
(in toxicology) Method providing information on the consequences for gene expression of interactions of the organism with environmental stress, xenobiotics, etc.
genotoxic Capable of causing a heritable change to the structure of DNA thereby producing a mutation.
genotype Genetic constitution of an organism as revealed by genetic or molecular analysis; the complete set of genes possessed by a particular organism, cell, organelle, or virus. After [42] glomerulus Tuft or a cluster, as of a plexus of capillary blood vessels or nerve fibers, e.g., capillaries of the filtration apparatus of the kidney. After [20] glomerular filtration Formation of an ultrafiltrate of the blood occurring in the glomerulus of the kidney.
glomerular filtration rate
Volume of ultrafiltrate formed in the kidney tubules from the blood passing through the glomerular capillaries divided by time of filtration.
half life, t 1/2 Time required for the concentration of a reactant in a given reaction to reach a value that is the arithmetic mean of its initial and final (equilibrium) values. For a reactant that is entirely consumed, it is the time taken for the reactant concentration to fall to one half its initial value.
Note: The half life of a reaction has meaning only in special cases:
1.
For a first-order reaction, the half life of the reactant may be called the half life of the reaction.
2.
For a reaction involving more than one reactant, with the concentrations of the reactants in stoichiometric ratios, the half life of each reactant is the same, and may be called the half life of the reaction. incidence Number of occurrences of illness commencing, or of persons falling ill, during a given period in a specific population: usually expressed as a rate.
Note: When expressed as a rate, it is the number of ill persons divided by the average number of persons in the specified population during a defined period, or alternatively divided by the estimated number of persons at the midpoint of that period.
[65]
infusion (in physiology) Therapeutic introduction of a fluid other than blood, as a (usually saline) solution, into a vein. After [19] interfacial layer Inhomogeneous region intermediate between two bulk phases in contact, and where properties are significantly different from, but related to, the properties of the bulk phases. [38] internal dose See preferred synonym: absorbed dose.
interstitial fluid
Aqueous solution filling the narrow spaces between cells.
intrinsic activity
Maximal stimulatory effect induced by a compound in relation to that of a given reference compound. After [57] intrinsic clearance Volume of plasma or blood from which a substance is completely removed in a period of time under unstressed conditions. intrinsic factor (in biochemistry) Specific protein required for the absorption of vitamin B 12 and secreted by cells in the gastric glands of the stomach.
kinetics (in chemistry)
Branch of chemistry concerned with measuring and studying rates of chemical reactions.
After [16] latency See synonym: latent period.
latent period 1.
Delay between exposure to a harmful substance and the manifestations of a disease or other adverse effects.
2.
Period from disease initiation to disease detection. After [20] lethal concentration, LC Concentration of a substance in an environmental medium that causes death following a certain period of exposure. [38] lethal dose, LD Amount of a substance or physical agent (e.g., radiation) that causes death when taken into the body. After [20, 38] lethal synthesis Metabolic formation of a highly toxic compound often leading to death of affected cells. After [20, 38] linearized multistage model Sequence of steps in which (a) a multistage model is fitted to tumor incidence data; (b) the maximum linear term consistent with the data is calculated; (c) the low-dose slope of the dose-response function is equated to the coefficient of the maximum linear term; and (d) the resulting slope is then equated to the upper bound of potency. [20] local effect Change occurring at the site of contact between an organism and a toxicant. [20] logit In competitive binding assays, the logit-log dose relationship, in which the response is defined by:
where y = b/b 0 with b = fraction of tracer bound and b 0 = value of b with no unlabeled ligand in the system.
Note: Logit transformed assay data frequently yield straight-line dose-response data, amenable to statistical analysis. More generally in toxicology, the transformation is applied to dose-response data, where b 0 denotes the maximum response in the absence of a toxic substance.
Modified from [38] ; see also [20] log-normal distribution Distribution function F(y), in which the logarithm of a quantity is normally distributed, i.e.,
F(y) = f gauss (ln y)
where f gauss (x) is a Gaussian distribution. [38] log-normal transformation Transformation of data with a logarithmic function that results in a normal distribution.
long-term effect
See synonym: chronic effect.
long-term exposure
See synonym: chronic exposure. lowest effective dose, LED Lowest dose of a chemical inducing a specified effect in a specified fraction of exposed individuals.
lowest lethal concentration found
See minimum lethal concentration.
lowest-observed-adverse-effect level, LOAEL
Lowest concentration or amount of a substance (dose), found by experiment or observation, which causes an adverse effect on morphology, functional capacity, growth, development, or life span of a target organism distinguishable from normal (control) organisms of the same species and strain under defined conditions of exposure. [38] lowest-observed-effect level, LOEL Lowest concentration or amount of a substance (dose), found by experiment or observation, that causes any alteration in morphology, functional capacity, growth, development, or life span of target organisms distinguishable from normal (control) organisms of the same species and strain under the same defined conditions of exposure. [20, 38] M. NORDBERG et al.
macrophage
Large (10-20 µm diameter) amoeboid and phagocytic cell found in many tissues, especially in areas of inflammation, derived from blood monocytes and playing an important role in host defense mechanisms. [20] margin of exposure, MOE Ratio of the no-observed-adverse-effect level (NOAEL) to the theoretical or estimated exposure dose (EED) or concentration (EEC). [20] margin of safety, MOS See synonym: margin of exposure. mass mean diameter Diameter of a spherical particle with a mass equal to the mean mass of all the particles in a population. [20] mass median diameter Diameter of a spherical particle with the median mass of all the particles in a population. [25] maximum tolerable concentration, MTC Highest concentration of a substance in an environmental medium that does not cause death of test organisms or species (denoted by LC 0 ). [20, 38] maximum tolerable dose, MTD Highest amount of a substance that, when introduced into the body, does not kill test animals (denoted by LD 0 ). [20, 38] maximum tolerable exposure level, MTEL Maximum amount (dose) or concentration of a substance to which an organism can be exposed without leading to an adverse effect after prolonged exposure time. [20, 38] maximum tolerated dose, MTD High dose used in chronic toxicity testing that is expected on the basis of an adequate subchronic study to produce limited toxicity when administered for the duration of the test period.
Note: It should not induce: (a) overt toxicity, for example appreciable death of cells or organ dysfunction, or (b) toxic manifestations that are predicted materially to reduce the life span of the animals except as the result of neoplastic development, or (c) 10 % or greater retardation of body weight gain as compared with control animals.
Note:
In some studies, toxicity that could interfere with a carcinogenic effect is specifically excluded from consideration. [20, 38] 
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Glossary of terms used in toxicokineticsmaximum velocity (maximum rate), V max In Michaelis-Menten kinetics, the maximum rate of conversion of a substrate when its concentration is not rate limiting. Synonym: maximum rate.
mean residence time, MRT (in pharmacokinetics)
Average time a drug molecule remains in the body or an organ after rapid intravenous injection.
Note 1: Like clearance, its value is independent of dose.
Note 2: After an intravenous bolus:
where t r is the MRT, A is the area under the plasma concentration-time curve, and A m is the area under the moment curve.
Note 3: For a drug with one-compartment distribution characteristics, MRT equals the reciprocal of the elimination rate constant.
After [6] median effective concentration, EC 50 Statistically derived concentration of a substance in an environmental medium expected to produce a certain effect in test organisms in a given population under a defined set of conditions. Note: EC n refers to the median concentration that is effective in n % of the test population. [20, 38] median effective dose, ED 50 Statistically derived dose of a chemical or physical agent (radiation) expected to produce a certain effect in test organisms in a given population or to produce a half-maximal effect in a biological system under a defined set of conditions. Note: ED n refers to the median dose that is effective in n % of the test population. [20, 38] median lethal concentration, LC 50 Statistically derived concentration of a substance in an environmental medium expected to kill 50 % of organisms in a given population under a defined set of conditions. [20, 38] median lethal dose, LD 50 Statistically derived dose of a chemical or physical agent (radiation) expected to kill 50 % of organisms in a given population under a defined set of conditions. [20, 38] median lethal time, TL 50 Statistically derived average time interval during which 50 % of a given population may be expected to die following acute administration of a chemical or physical agent (radiation) at a given concentration under a defined set of conditions. [20, 38] M. NORDBERG et al. After [20] metabolic model Analysis and theoretical reconstruction of the way in which the body deals with a specific substance, showing the proportion of the intake that is absorbed, the proportion that is stored and in what tissues, the rate of breakdown in the body and the subsequent fate of the metabolic products, and the rate at which it is eliminated (see elimination) by different organs as unchanged substance or metabolites. [65] metabolic transformation Biotransformation of a substance that takes place within a living organism. After [20] metabolism Sum total of all physical and chemical processes that take place within an organism; in a narrower sense, the physical and chemical changes that take place in a substance within an organism.
Note: It includes the uptake and distribution within the body of a substance, the changes (biotransformation) undergone by such a substance, and the elimination of the substance and of its metabolites. [65] metabolite Intermediate or product resulting from metabolism. After [38] metabonomics Evaluation of tissues and biological fluids for changes in metabolite levels that follow exposure to a given substance, in order to determine the metabolic processes involved and to evaluate the disruption in intermediary metabolic processes that results from exposure to that substance.
Michaelis constant, K M Substance concentration of substrate at which the rate of reaction is equal to one half of the limiting rate (maximum rate). Also called the Michaelis concentration. The Michaelis constant (Michaelis concentration) may be used only when Michaelis-Menten kinetics is obeyed. [38] Michaelis-Menten kinetics Dependence of an initial rate of reaction upon the total concentration of a substrate S that is present in large excess over the concentration of an enzyme or other catalyst (or reagent) E with the appearance of saturation behavior following the Michaelis-Menten equation:
where v is the observed initial rate, V is its limiting value at substrate saturation (i.e., From [38] with a more logical symbol for the Michaelis constant, and with notation consistent with Michaelis-Menten mechanism.
Michaels-Menten mechanism
Michaelis-Menten mechanism is the simplest mechanism that will explain Michaelis-Menten kinetics. According to the mechanism, a substrate S first combines with a molecule of enzyme E, and this process is followed by a step in which the enzyme-substrate complex ES breaks down (sometimes with the participation of the solvent) into enzyme and reaction products:
If, as is usual, the substrate S is present in great excess of the enzyme, it can be shown that steady-state conditions apply, and that the rate equation is:
where After [7, 62, 72] Monte Carlo study Simulation and analysis of a sequence of events using random numbers to generate possible outcomes in an iterative process.
mucociliary transport
Process of removal of particles from the bronchi of the lungs in a mucus stream moved by cilia, thus contributing to uptake from the gastrointestinal tract.
Mulliken population analysis
Partitioning scheme based on the use of density and overlap matrices, at one time used for allocating the electrons of a molecular entity in some fractional manner among its various parts (atoms, bonds, orbitals).
multicompartment model
Product of a compartmental analysis requiring more than two compartments.
multipotent
Of a cell, capable of giving rise to several different kinds of structure or types of cell.
multistage model Dose-response model for cancer death estimation of the form
where P is the probability of cancer death from a continuous dose rate, d i , of group (or stage) i, the q's are constants, and k is the number of dose groups (or, if less than the number of dose groups, k is the number of biological stages believed to be required in the carcinogenesis process). With the multistage model, it is assumed that cancer is initiated by cell mutations in a finite series of steps. [20] multivariate statistics Set of statistical tools to analyze data matrices using regression and/or pattern recognition techniques.
mutagen
Agent that can induce heritable changes (mutations) of the genotype in a cell as a consequence of alterations or loss of genetic material. After [20] necrosis Sum of morphological changes resulting from cell death by lysis and/or enzymatic degradation, usually affecting groups of cells in a tissue. See also apoptosis.
negligible risk 1. Probability of adverse effects occurring that can reasonably be described as trivial. 2.
Probability of adverse effects occurring that is so low that it cannot be reduced appreciably by increased regulation or investment of resources. [20] no-effect level, NEL Maximum dose (of a substance) that produces no detectable changes under defined conditions of exposure.
Note: This term tends to be substituted by no-observed-adverse-effect level (NOAEL) or no-observed-effect level (NOEL). [20] no-observed-adverse-effect level, NOAEL Greatest concentration or amount of a substance, found by experiment or observation, which causes no detectable adverse alteration of morphology, functional capacity, growth, development, or life span of the target organism under defined conditions of exposure. [38, 61] no-observed-effect level, NOEL Greatest concentration or amount of a substance, found by experiment or observation, that causes no alterations of morphology, functional capacity, growth, development, or life span of target organisms distinguishable from those observed in normal (control) organisms of the same species and strain under the same defined conditions of exposure. [20, 38] one-compartment model Kinetic model, where the whole body is thought of as a single compartment in which the substance distributes rapidly, achieving an equilibrium between blood and tissue immediately. [63] M. NORDBERG et al.
one-hit model
Dose-response model of the form pharmacodynamics Process of interaction of pharmacologically active substances with target sites in living systems, and the biochemical and physiological consequences leading to therapeutic or adverse effects. Corrected from [38] ; see also [20] .
pharmacogenetics Study of the influence of genetic factors on the effects of drugs on individual organisms. After [20] 
Process of the uptake of drugs by the body, the biotransformation they undergo, the distribution of the drugs and their metabolites in the tissues, and the elimination of the drugs and their metabolites from the body over a period of time.
2.
Study of such processes. After [20, 38] pharmacology Science of the use and effects of drugs: may be subdivided into pharmacokinetics and pharmacodynamics defined above.
phase I reaction (of biotransformation)
Enzymic modification of a substance by oxidation, reduction, hydrolysis, hydration, dehydrochlorination, or other reactions catalyzed by enzymes of the cytosol, of the endoplasmic reticulum (microsomal enzymes) or of other cell organelles. [20] See also cytochrome P450.
phase II reaction (of biotransformation)
Binding of a substance, or its metabolites from a phase 1 reaction, with endogenous molecules (conjugation), making more water-soluble derivatives that may be excreted in the urine or bile. [20] phase III reaction (of biotransformation) Further metabolism of conjugated metabolites produced by phase II reactions. After [20] phenotype Observable structural and functional characteristics of an organism determined by its genotype and modulated by its environment. [38, 42] physiological availability See bioavailability.
physiological pharmacokinetic model
See physiologically based pharmacokinetic modeling.
M. NORDBERG et al.
physiologically based pharmacokinetic modeling, PBPK Mathematical modeling of kinetic behavior of a substance, based on measured physiological parameters. Synonym: toxicologically based pharmacokinetic modeling pinocytosis Type of endocytosis in which soluble materials are taken up by the cell and incorporated into vesicles for digestion. After [3] pivotal study See synonym: critical study.
Fluid component of blood in which the blood cells and platelets are suspended. Synonym: blood plasma [20] 2.
Fluid component of semen produced by the accessory glands, the seminal vesicles, the prostate, and the bulbo-urethral glands [20] 3.
Cell substance outside the nucleus, i.e., the cytoplasm. [20] poison (in toxicology) Substance that, taken into or formed within the organism, impairs the health of the organism and may kill it. After [20] population at risk Persons who can and may develop an adverse health effect and who are potentially exposed to a substance under study. People already having chronic disease are excluded from the population at risk in studies of the incidence of the adverse effect. [61] potency (in toxicology) Expression of relative toxicity of an agent as compared to a given or implied standard or reference. After [20] potentiation Dependent action in which a substance or physical agent at a concentration or dose that does not itself have an adverse effect enhances the harm done by another substance or physical agent. [20, 38] procarcinogen Substance that has to be metabolized before it becomes a carcinogen. After [20] prodrug Precursor converted to an active form of a drug within the body.
prosthetic group
Non-protein entity essential for an enzyme's activity and tightly bound to the enzyme molecule in its active form.
proteome Complete set of proteins encoded by the genome.
proteomics Global analysis of gene expression using a variety of techniques to identify and characterize proteins.
Note: It can be used to study changes caused by exposure to chemicals and to determine if changes in mRNA expression correlate with changes in protein expression: the analysis may also show changes in post-translational modification, which cannot be distinguished by mRNA analysis alone.
pulmonary

Pertaining to the lung(s).
quantal Describing a condition that can be expressed only as occurring or not occurring, such as death. After [20] quantitative structure-activity relationships, QSAR Quantitative structure-biological activity models derived using regression analysis and containing as parameters physicochemical constants, indicator variables, or theoretically calculated values.
Note:
The term is extended by some authors to include chemical reactivity, i.e., activity and reactivity are regarded as synonyms. The extension is discouraged.
Modified from [38] ; see also [20] .
quantitative structure-metabolism relationship, QSMR Quantitative association between the physicochemical and/or the structural properties of a substance and its metabolic behavior. rate (in epidemiology) Measure of the frequency with which an event occurs in a defined population in a specified period of time.
Note 1: Most such rates are ratios, calculated by dividing a numerator, e.g., the number of deaths, or newly occurring cases of a disease in a given period, by a denominator, e.g., the average population during that period.
Note 2: Some rates are proportions, i.e., the numerator is contained within the denominator.
After [35] rate constant, k Proportionality that relates the rate of a chemical reaction to some function of reactant concentrations. After [40] M. NORDBERG et al.
rate-limiting step
Single step in a multistep reaction, the rate constant for which exerts a dominant effect on the overall rate.
reactive oxygen species, ROS Intermediates in the reduction of molecular O 2 to water.
Examples: superoxide O 2 -• , hydrogen peroxide H 2 O 2 , and hydroxyl HOؒ.
receptor Molecular structure in or on a cell that specifically recognizes and binds to a compound and acts as a physiological signal transducer, or mediator of, an effect. Modified from [38] .
receptor-mediated endocytosis
Endocytosis of a substance and its receptor following receptor binding.
reconstitution
Restoration to original form of a substance previously altered for preservation and storage. After [19] reference dose, RfD Term used for an estimate (with uncertainty spanning perhaps an order of magnitude) of a daily exposure to the human population (including sensitive subgroups) that is likely to be without appreciable risk of deleterious effects during a lifetime. [5] regioselectivity, regioselective Terms referring to a reaction in which one direction of bond making or breaking occurs preferentially over all other possible directions.
Note: Reactions are termed completely (100 %) regioselective if the discrimination is complete, or partially (x %), if the product of reaction at one site predominates over the product of reaction at other sites.
second messenger Intracellular effector substance increasing or decreasing as a response to the stimulation of a receptor by an agonist, considered as the 'first messenger'. After [57] serum 1. Watery proteinaceous portion of the blood that remains after clotting. Synonym: blood serum 2.
Clear watery fluid especially that moistening the surface of serous membranes or that exuded through inflammation of any of these membranes. [20] short-term exposure limit, STEL Fifteen-minute time-weighted average (TWA) exposure recommended by ACGIH which should not be exceeded at any time during a workday, even if the 8-h TWA is within the threshold limit value-timeweighted average, TLV-TWA. [2] speciation (in chemistry) Distribution of an element amongst defined chemical species in a system. [52] speciation analysis (in chemistry) Analytical activities of identifying and/or measuring the quantities of one or more individual chemical species in a sample. [52] steady state (in chemistry) State of a system in which properties do not change with time. [40] steady state (in toxicology) State of a system in which the conditions do not change in time. After [40] stem cell Multipotent cell with mitotic potential that may serve as a precursor for many kinds of differentiated cells.
stereoselective synthesis
Chemical reaction (or reaction sequence) in which one or more new elements of chirality are formed in a substrate molecule and which produces the stereoisomeric (enantiomeric or diastereoisomeric) products in unequal amounts. Traditionally called asymmetric synthesis. [41] stereoselectivity Specificity of chemical reactivity of stereoisomers based on their three-dimensional molecular structure.
stochastic
Pertaining to or arising from chance and hence obeying the laws of probability. After [65] stochastic effect, stochastic process Phenomenon pertaining to or arising from chance, and hence obeying the laws of probability. After [20] structure-activity relationship, SAR Association between specific aspects of molecular structure and defined biological action. [20] See also quantitative structure-activity relationship. structure-metabolism relationship, SMR Association between the physicochemical and/or the structural properties of a substance and its metabolic behavior.
subacute (effect) See subchronic (effect).
subchronic Repeated over a short period, usually about 10 % of the life span; an imprecise term used to describe exposures of intermediate duration. [20] subchronic effect Biological change resulting from an environmental alteration lasting about 10 % of the lifetime of the test organism.
Note: In practice with experimental animals, such an effect is usually identified as resulting from multiple or continuous exposures occurring over 3 months (90 days). Sometimes a subchronic effect is distinguished from a subacute effect on the basis of its lasting for a much longer time. [20] subchronic toxicity test Animal experiment serving to study the effects produced by a test substance when administered in repeated doses (or continually in food, drinking-water, air) over a period of up to about 90 days. [61] susceptible Describing a group of organisms more vulnerable to a given exposure than the majority of the population to which they belong.
Note: Susceptibility may reflect gender, age, physiological status, or genetic constitution of the organisms at risk.
synergism (in toxicology)
Pharmacological or toxicological interaction in which the combined biological effect of two or more substances is greater than expected on the basis of the simple summation of the toxicity of each of the individual substances. [20, 38] synergistic effect See synergism. systemic Relating to the body as a whole. After [20] systemic effect Consequence that is either of a generalized nature or that occurs at a site distant from the point of entry of a substance.
Note: A systemic effect requires absorption and distribution of the substance in the body. [20] target (in biology) Any organism, organ, tissue, cell, or cell constituent that is subject to the action of an agent. After [61] three-dimensional quantitative structure-activity relationship, 3D-QSAR Quantitative association between the three-dimensional structural properties of a substance and its biological properties. See quantitative structure-activity relationship.
threshold Dose or exposure concentration below which an effect will not occur. After [20] threshold concentration See threshold.
threshold dose See threshold.
threshold limit value-ceiling, TLV-C Concentration of a potentially toxic substance that should not be exceeded during any part of the working exposure. [2] threshold limit value-time-weighted average, TLV-TWA Time-weighted average concentration for a conventional 8-h workday and a 40-h workweek, to which it is believed nearly all workers may be repeatedly exposed, day after day, without adverse effect. [2] M. NORDBERG et al. toxicity equivalency factor, TEF, f Factor used in risk assessment to estimate the toxicity of a complex mixture, most commonly a mixture of chlorinated dibenzo-p-dioxins, furans, and biphenyls: in this case, TEF is based on relative toxicity to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TEF = 1). [20] toxicity equivalent, TEQ Contribution of a specified component (or components) to the toxicity of a mixture of related substances. The amount-of-substance (or substance concentration) of total toxicity equivalent is the sum of that for the n components B, C … N. Toxicity equivalent is most commonly used in relation to the reference toxicant 2,3,7,8-tetrachlorodibenzo-p-dioxin by means of the toxicity equivalency factor (TEF, f) which is 1 for the reference substance. Hence:
After [20] toxic substance Substance causing injury to living organisms as a result of physicochemical interactions.
toxicity test
Experimental study of the adverse effects of exposure of a living organism to a substance for a defined duration under defined conditions. [20] toxicodynamics Process of interaction of potentially toxic substances with target sites, and the biochemical and physiological consequences leading to adverse effects. [20, 38] toxicogenetics Study of the influence of hereditary factors on the effects of potentially toxic substances on individual organisms. [20] toxicokinetics Process of the uptake of potentially toxic substances by the body, the biotransformation they undergo, the distribution of the substances and their metabolites in the tissues, and the elimination of the substances and their metabolites from the body. [20, 38, 61] toxicologically based pharmacokinetic modeling, TBPK See physiologically based pharmacokinetic modeling. toxicology Scientific discipline involving the study of the actual or potential danger presented by the harmful effects of substances on living organisms and ecosystems, of the relationship of such harmful effects to exposure, and of the mechanisms of action, diagnosis, prevention, and treatment of intoxications. [20, 38] Poisonous substance produced by a biological organism such as a microbe, animal, or plant. [20, 38] tracer substance Substance which can be tracked through one or more reactions or systems, often by detecting an incorporated isotope.
transcriptomics Global analysis of gene expression to identify and evaluate changes in synthesis of mRNA after chemical exposure.
transformed cell
Cell which has become genetically altered spontaneously or by incorporation of foreign DNA to produce a cell with an extended lifetime in culture. In assay methodology, confidence interval or fiducial limit used to assess the probable precision of an estimate. 2.
In toxicology, value used in extrapolation from experimental animals to man (assuming that man may be more sensitive) or from selected individuals to the general population. For example, a value applied to the no-observed-effect-level (NOEL) or no-observed-adverse-effect level (NOAEL) to derive an acceptable daily intake (ADI) or tolerable daily intake (TDI).
Note:
The NOEL or NOAEL is divided by the value of the UF to calculate the ADI or TDI.
After [20] See modifying factor, safety factor.
unit risk
Upper-bound excess lifetime cancer risk estimated to result from continuous exposure to an agent at a concentration of 1 µg l -1 in water, or 1 µg m -3 in air.
Note: The excess interpretation of unit risk would be as follows: if unit risk = 1.5 × 10 -6 µg l -1 , 1.5 excess tumors are expected to develop per 10 6 people if exposed daily for a lifetime to 1 µg of the chemical in 1 litre of drinking water. Glossary of terms used in toxicokineticsuptake Entry of a substance into the body, into an organ, into a tissue, into a cell, or into the body fluids by passage through a membrane or by other means. [20] volume of distribution Apparent (hypothetical) volume of fluid required to contain the total amount of a substance in the body at the same concentration as that present in the plasma, assuming equilibrium has been attained. [20] xenobiotic Compound with a chemical structure foreign to a given organism.
Note:
The term is frequently restricted to manmade compounds.
After [20, 38, 42] zero-order kinetics Kinetics of a reaction in which the rate is independent of the concentration(s) of the reactants. 
